Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Total Liabilities 2009–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cyclacel Pharmaceuticals, Inc. total liabilities for the quarter ending December 31, 2025 were 1.3M, a 78.57% decrease year-over-year.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2025 were 1.3M, a 78.57% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2024 were 6.3M, a 23.54% decrease from 2023.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2023 were 8.2M, a 7.63% increase from 2022.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2022 were 7.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cyclacel Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2024 | $6 |
| 2023 | $8 |
| 2022 | $8 |
| 2021 | $5 |
| 2020 | $4 |
| 2018 | $5 |
| 2017 | $4 |
| 2016 | $5 |
| 2015 | $6 |
| 2014 | $8 |
| 2013 | $7 |
| 2012 | $9 |
| 2011 | $6 |
| 2010 | $7 |
| Cyclacel Pharmaceuticals, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $1 |
| 2024-12-31 | $6 |
| 2023-12-31 | $8 |
| 2022-12-31 | $8 |
| 2021-12-31 | $5 |
| 2020-12-31 | $4 |
| 2018-12-31 | $5 |
| 2017-12-31 | $4 |
| 2016-12-31 | $5 |
| 2015-12-31 | $6 |
| 2014-12-31 | $8 |
| 2013-12-31 | $7 |
| 2012-12-31 | $9 |
| 2011-12-31 | $6 |
| 2010-12-31 | $7 |
Cyclacel Pharmaceuticals, Inc. Total Liabilities — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's total liabilities history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.